Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
Saeko Fujiwara,1 Etsuro Hamaya,2 Masayo Sato,2 Peita Graham-Clarke,3 Jennifer A Flynn,2 Russel Burge41Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan; 2Lilly Research Laboratories Japan, Eli Lilly Japan K.K., Kobe, Japan; 3Global Health Outcomes, Eli Lilly Australia, Sydney, NSW, Australia;...
Enregistré dans:
Auteurs principaux: | Fujiwara S, Hamaya E, Sato M, Graham-Clarke P, Flynn JA, Burge R |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3886d91cf4b049a3a06a9d81815d51fb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prevalence rate of osteoporosis complications in Ulan-Ude residents
par: T. I. Batudaeva, et autres
Publié: (2015) -
Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
par: Victor G Vogel
Publié: (2008) -
Optimización perioperatoria del paciente anciano con fractura osteoporótica de cadera
par: Bengoa,Francisco, et autres
Publié: (2017) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
par: Luigi Gennari, et autres
Publié: (2010) -
Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
par: Masashi Uehara, et autres
Publié: (2021)